Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

Crystalys banks $130m to progress gout drug, plan for commercial readiness

The funds will help Crystalys progress its clinical-stage development efforts and commercialisation plans for dotinurad.

Latest news

Samsung Biologics: geographic diversification is a sound business decision

Executive vice-president James Choi discusses the CDMO’s growth strategy and acquiring its first US manufacturing site from GSK.

Speciality versus diversity: the four-way CDMO race in outsourced HPAPI manufacturing

GlobalData’s Drugs By Manufacturer Database reveals the top four CDMOs for innovator and biosimilar HPAPI contract manufacturing, with Lonza and Siegfried leading the race.

Evogene and ELEO to develop new oral PCSK9 inhibitors

ELEO will provide experimental resources and screening platforms to test and refine molecules produced via computational methods.

US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028

If introduced, the 100% tariffs would apply to all generics imported to the US, which make up 90% of the nation’s prescriptions.

Novo sues Lilly after alleged misleading and false advertising campaign

In a lawsuit filed in the US, Novo alleged that Lilly’s campaign was designed to mislead consumers on “comparative efficacy” of drug brands.